Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAT2A | P31153 | 1/20 | 0.36 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.36 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.35 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.35 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.35 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.34 |
| ▸ | SYK | P43405 | 2/20 | 0.34 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.34 |
| ▸ | AR | P10275 | 3/20 | 0.33 |
| ▸ | FNTA | P49354 | 1/20 | 0.33 |
| ▸ | FNTB | P49356 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | RORC | P51449 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | PGR | P06401 | 1/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.33 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.33 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.33 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.33 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1947965 | 0.94 | MAT2A (0.34) | MAT2APTPN5TGFBR1ENPP1CLK4 | |
| SCHEMBL1949835 | 0.88 | PTPN5 (0.37) | MAT2APTPN5TGFBR1ENPP1CLK4 | |
| SCHEMBL1949350 | 0.86 | PTPN5 (0.36) | MAT2APTPN5TGFBR1ENPP1CLK4 | |
| SCHEMBL1948959 | 0.86 | KIF11 (0.40) | PTPN5ARTRPA1 | |
| SCHEMBL1948131 | 0.85 | ENPP1 (0.39) | MAT2APTPN5TGFBR1ENPP1CLK4 | |
| SCHEMBL1951047 | 0.82 | CYP11B2 (0.35) | MAT2ATGFBR1 | |
| SCHEMBL1947933 | 0.82 | PTPN5 (0.35) | MAT2APTPN5TGFBR1ENPP1CLK4 | |
| SCHEMBL1950235 | 0.81 | KIF11 (0.38) | — | |
| SCHEMBL1951318 | 0.80 | ENPP1 (0.38) | MAT2APTPN5TGFBR1ENPP1CLK4 | |
| SCHEMBL1948399 | 0.78 | KIF11 (0.37) | PTPN5TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9084420-B2 | Amide derivative, pest control agent containing the amide derivative, and pest controlling method | MITSUI CHEMICALS AGRO, INC. (JP) | 2015-07-21 | — | — | US | disclosed |
| US-20140107368-A1 | AMIDE DERIVATIVE, PEST CONTROL AGENT CONTAINING THE AMIDE DERIVATIVE, AND PEST CONTROLLING METHOD | MITSUI CHEMICALS AGRO, INC. (JP) | 2014-04-17 | — | — | US | disclosed |
| US-8633228-B2 | Amide derivative, pest control agent containing the amide derivative, and pest controlling method | MITSUI CHEMICALS AGRO, INC. (JP) | 2014-01-21 | — | — | US | disclosed |
| US-20110136878-A1 | AMIDE DERIVATIVE, PEST CONTROL AGENT CONTAINING THE AMIDE DERIVATIVE, AND PEST CONTROLLING METHOD | Mitsui Chemicals Agro., Inc. (JP) | 2011-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110136878-A1 | AMIDE DERIVATIVE, PEST CONTROL AGENT CONTAINING THE AMIDE DERIVATIVE, AND PEST CONTROLLING METHOD | L3MBTL1, L3MBTL4, L3MBTL3 | MAT2A 3020/4885PTPN5 1167/4885TGFBR1 1620/4885 |
| US-20140107368-A1 | AMIDE DERIVATIVE, PEST CONTROL AGENT CONTAINING THE AMIDE DERIVATIVE, AND PEST CONTROLLING METHOD | L3MBTL1, L3MBTL4, L3MBTL3 | MAT2A 3020/4885PTPN5 1167/4885TGFBR1 1620/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.